Here’s what you need to know:
1. Patients of NueHealth’s provider networks will have access to three screening types, including ColonSentry, a screening test that provides early risk stratification for colorectal cancer.
2. ColonSentry utilizes a blood test, which measures the expression of gene biomarkers that are early warning signs of colorectal cancer.
3. The tests will be processed by GeneNews at a clinical reference lab in Richmond, Va.
More articles on gastroenterology and endoscopy:
Vitamin A metabolite may suppress colorectal cancer: 5 study insights
Hannibal Regional Medical Group adds Dr. Ashraf Almashhrawi: 5 things to know
Migraines associated with GI disorders: 5 study insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
